Published in Syst Rev on July 25, 2013
Methodological quality of meta-analyses on treatments for chronic obstructive pulmonary disease: a cross-sectional study using the AMSTAR (Assessing the Methodological Quality of Systematic Reviews) tool. NPJ Prim Care Respir Med (2015) 1.17
Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis. Int J Clin Exp Pathol (2014) 0.92
Mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: a systematic review and meta-analysis. PLoS One (2014) 0.81
Dissemination bias in systematic reviews of animal research: a systematic review. PLoS One (2014) 0.78
Diagnostic Performance of Indocyanine Green-Guided Sentinel Lymph Node Biopsy in Breast Cancer: A Meta-Analysis. PLoS One (2016) 0.77
Contradicting/negative results in clinical research: Why (do we get these)? Why not (get these published)? Where (to publish)? Perspect Clin Res (2014) 0.75
Dietitians and Nutritionists: Stigma in the Context of Obesity. A Systematic Review. PLoS One (2015) 0.75
Factors influencing biochemical recurrence in patients who have received salvage radiotherapy after radical prostatectomy: a systematic review and meta-analysis. Asian J Androl (2016) 0.75
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
Publication bias in clinical research. Lancet (1991) 22.85
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics (2000) 19.26
Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32
Publication bias: the case for an international registry of clinical trials. J Clin Oncol (1986) 12.14
Trial Registration at ClinicalTrials.gov between May and October 2005. N Engl J Med (2005) 11.89
The existence of publication bias and risk factors for its occurrence. JAMA (1990) 8.70
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Publication and related biases. Health Technol Assess (2000) 6.47
Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol (1994) 6.01
Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess (2010) 5.11
Compulsory registration of clinical trials. BMJ (2004) 4.28
NIH clinical trials and publication bias. Online J Curr Clin Trials (1993) 3.41
In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol (2005) 2.77
Protocol for a systematic review on the extent of non-publication of research studies and associated study characteristics. Syst Rev (2013) 1.07
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43
Randomized trials stopped early for benefit: a systematic review. JAMA (2005) 8.43
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet (2009) 6.92
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med (2015) 6.06
Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA (2010) 5.90
Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ (2013) 5.78
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77
Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ (2013) 5.08
Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J (2006) 4.38
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA (2013) 4.33
Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med (2006) 4.19
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ (2010) 3.54
Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet (2008) 3.29
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst (2006) 3.23
Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet (2006) 3.17
Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol (2008) 3.06
Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med (2011) 2.97
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 2.95
Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers. J Clin Oncol (2011) 2.72
Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid. J Clin Epidemiol (2011) 2.69
Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ (2012) 2.69
Have online international medical journals made local journals obsolete? PLoS Med (2006) 2.64
Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern Med (2013) 2.59
Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med (2005) 2.55
Medication effects on the rate of orthodontic tooth movement: a systematic literature review. Am J Orthod Dentofacial Orthop (2009) 2.54
GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol (2013) 2.46
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol (2009) 2.45
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
Comments on 'Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death'. Stat Med (2008) 2.37
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev (2012) 2.31
Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med (2007) 2.21
Systematic reviewers neglect bias that results from trials stopped early for benefit. J Clin Epidemiol (2007) 2.20
Early stopping of randomized clinical trials for overt efficacy is problematic. J Clin Epidemiol (2008) 2.18
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Evid Based Child Health (2013) 2.12
Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology (2010) 2.10
Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. BMJ (2007) 2.07
Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ (2005) 2.03
The ribosomal basis of Diamond-Blackfan Anemia: mutation and database update. Hum Mutat (2010) 2.03
Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol (2011) 2.02
Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers. J Clin Oncol (2012) 2.00
Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors. Am J Med (2011) 1.87
GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol (2012) 1.86
Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ (2012) 1.85
Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev (2011) 1.82
STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest (2009) 1.82
Systematic review of reviews including animal studies addressing therapeutic interventions for sepsis. Crit Care Med (2010) 1.78
Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev (2011) 1.78
RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations. Br J Haematol (2004) 1.76
Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis. J Natl Cancer Inst (2007) 1.69
Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review. Br J Ophthalmol (2010) 1.67
Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis (2012) 1.67
Five steps to conducting a systematic review. J R Soc Med (2003) 1.64
Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Stat Med (2009) 1.64
Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis. J Natl Cancer Inst (2005) 1.64
The scandal of poor epidemiological research. BMJ (2004) 1.60
Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. PLoS One (2012) 1.56
A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg (2007) 1.55
Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT). Blood (2006) 1.54
Arcsine test for publication bias in meta-analyses with binary outcomes. Stat Med (2008) 1.49
The Clinical Effectiveness of Pneumococcal Conjugate Vaccines. Dtsch Arztebl Int (2016) 1.49
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective. Clin Chem Lab Med (2015) 1.48
The National Institutes of Health and guidance for reporting preclinical research. BMC Med (2015) 1.48
Inconsistent definitions for intention-to-treat in relation to missing outcome data: systematic review of the methods literature. PLoS One (2012) 1.48
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet (2009) 1.47
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. Cochrane Database Syst Rev (2008) 1.45
Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review. BMC Med (2012) 1.45
Association between research sponsorship and study outcome in plastic surgery literature. Ann Plast Surg (2009) 1.45
Editorial policies of pediatric journals: survey of instructions for authors. Arch Pediatr Adolesc Med (2010) 1.44
Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. BMJ (2006) 1.41
Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers. PLoS One (2013) 1.40
A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandard. PLoS One (2012) 1.38
Colchicine for prevention of cardiovascular events. Cochrane Database Syst Rev (2016) 1.38
Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev (2011) 1.33
Assessing the sensitivity of meta-analysis to selection bias: a multiple imputation approach. Biometrics (2010) 1.33
LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact. Trials (2009) 1.32
Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev (2012) 1.28
Google Scholar as replacement for systematic literature searches: good relative recall and precision are not enough. BMC Med Res Methodol (2013) 1.27
Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. Cochrane Database Syst Rev (2009) 1.26
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol (2009) 1.25
The new CONSORT statement. BMJ (2010) 1.25
Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics (2010) 1.25
The pylorus: take it or leave it? Systematic review and meta-analysis of pylorus-preserving versus standard whipple pancreaticoduodenectomy for pancreatic or periampullary cancer. Ann Surg Oncol (2007) 1.24
Meta-analyses: what they can and cannot do. Swiss Med Wkly (2012) 1.23
Inflation of type I error rate in two statistical tests for the detection of publication bias in meta-analyses with binary outcomes. Stat Med (2002) 1.23
Prehospital emergency care and the global road safety crisis. JAMA (2004) 1.21
Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Pediatr Nephrol (2011) 1.20
Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles. BMJ (2011) 1.19
Do urology journals enforce trial registration? A cross-sectional study of published trials. BMJ Open (2011) 1.19